Neuroleptic malignant syndrome: a report of a case and review of the literature.
A case of NMS was reported. NMS is an uncommon but potentially lethal complication of treatment with neuroleptics. The diagnosis of NMS should seriously be considered in any individual receiving neuroleptic medications who develops unexplained fever associated with muscle rigidity. The discontinuation of neuroleptics and the use of general supportive measures are crucial. On the basis of more rapid clinical response, either bromocriptine or dantrolene could be added to traditional supportive care.
Kanchanapongkul
J
J
Department of Medicine, Chon Buri Hospital, Thailand.
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects; D001971:Bromocriptine / Q000627:therapeutic use; D002908:Chronic Disease; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis; D013785:Thailand
D014150:Antipsychotic Agents; D001971:Bromocriptine